MD Anderson Research Highlights Special Edition: 2024 World Conference on Lung Cancer
September 10, 2024
September 10, 2024
HOUSTON, Texas, Sept. 10 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following research highlight:
* * *
Featuring promising clinical advances for treating lung cancer, including pre- and post-surgical immunotherapy and treatments targeting mutant HER2 and EGFR
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer resea . . .
* * *
Featuring promising clinical advances for treating lung cancer, including pre- and post-surgical immunotherapy and treatments targeting mutant HER2 and EGFR
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer resea . . .